tamoxifen and raloxifene for preventing breast cancer

The National Cancer Institute is starting a HUGE study to compare tamoxifen and raloxifene for preventing breast cancer.

It's called STAR..."Study of Tamoxifen And Raloxifene."

Tamoxifen (Nolvadex) reduces the risk of breast cancer by almost 50% in high-risk women.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote